DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% Drug Patent Profile
✉ Email this page to a colleague
When do Dobutamine Hydrochloride In Dextrose 5% patents expire, and when can generic versions of Dobutamine Hydrochloride In Dextrose 5% launch?
Dobutamine Hydrochloride In Dextrose 5% is a drug marketed by Hospira and Baxter Hlthcare and is included in three NDAs.
The generic ingredient in DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% is dobutamine hydrochloride. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dobutamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dobutamine Hydrochloride In Dextrose 5%
A generic version of DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% was approved as dobutamine hydrochloride by HOSPIRA on November 29th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%?
- What are the global sales for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%?
- What is Average Wholesale Price for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%?
Summary for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Clinical Trials: | 117 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% at DailyMed |
Recent Clinical Trials for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu | N/A |
| Koç University | N/A |
| Wuhan Union Hospital, China | Phase 2/Phase 3 |
See all DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% clinical trials
US Patents and Regulatory Information for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% | dobutamine hydrochloride | INJECTABLE;INJECTION | 020269-001 | Oct 19, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare | DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER | dobutamine hydrochloride | INJECTABLE;INJECTION | 020255-005 | Oct 19, 1993 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Baxter Hlthcare | DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER | dobutamine hydrochloride | INJECTABLE;INJECTION | 020255-001 | Oct 19, 1993 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER | dobutamine hydrochloride | INJECTABLE;INJECTION | 020201-003 | Oct 19, 1993 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
